RUTHFULLY YOURS

https://www.tabletmag.com/sections/news/articles/soviet-jews-stood-up-to-anti-zionism-once-before

Soviet Jews stood up to anti-Zionism once before. Now they are helping the younger generation of American Jews—including their own children—fight back against a wave of defamation and hate, while mainstream Jewish organizations wilt.

At a recent United Against Terrorism rally in Beverly Hills, Jennifer Karlan, 17, spoke passionately about why American Jews should stand for Israel. With remarkable confidence, she talked about a new form of antisemitism facing American Jews: “Today, they no longer say they hate the Jew; today they say they hate Zionists. Today they no longer say they hate the Jewish people; they say they hate the Zionist entity. But the hate is the same.” Some 2,000 people had gathered for the rally. Karlan drew cheers as she insisted that Jewish identity and Israel are deeply interconnected: “Israel is not just the name of the land; it is the name of our people. We are the people of Israel, each and every one of us: Am Yisrael Chai.” 

Karlan is a graduate of Club Z, a Zionist club for teens and quite possibly the most important American Jewish organization you’ve never heard of. Club Z was founded four years ago by Masha Merkulova, a Soviet Jewish immigrant from Minsk. Along with a handful of other organizations that Russian-speaking American Jews have started over the past few years, it is changing the conversation about Jewish identity, Jewish peoplehood, Zionism, and Israel. Disappointed with the way the United States’ organized Jewish community has treated these issues, and alarmed by the growing embrace of politically weaponized Zionophobia—the form of antisemitism that they know so well from their lives in the Soviet Union—these immigrants are taking matters into their own hands.

The recent Hamas-Israel confrontation unleashed an antisemitic onslaught on social media and in the streets of U.S. cities of a kind that American Jews had never seen before. It wasn’t just the intensity of the hate that was shocking—it was also its source and nature. Suddenly, violent antisemitism was coming at American Jews from the left. Suddenly, it was progressive politicians who were fanning the flames of antisemitism, while the Democratic Party—the political home of most American Jews—looked the other way. Nothing in American Jews’ background or system of beliefs had prepared them for this moment, and many did not seem to know how to respond.

In that moment of crisis, only a few individuals and groups stood out as they fearlessly fought hate and propaganda. They did not log off their social media accounts. They showed no signs of confusion, and they most certainly were not demoralized. They simply stood up and joined the battle against what they perceived as an assault not only Israel but on who they were as Jews. 

https://swtotd.blogspot.com/

Most of us conservatives who take our politics seriously have struggled with the phenomenon that was (and is) Donald Trump. We were taught that character matters, but we also know that so do issues. When they collide, on which side should we stand?

All of us, regardless of political leanings, struggle to fit today’s partisan political environment into the moral universe we inherited. As a conservative, I struggle to keep my moral compass firmly fixed in a world turned increasingly woke, where facts are subordinated to the narrative, where truth is relative and where censorship is applied. As an essayist, it is not my function to convince the reader of the righteousness of my positions, but to explain why I believe as I do. The ethical standards I apply to political thought are based on my parents, lessons from school and college, from travel and conversations, and from reading.

I grew up during and just after World War II, when distinctions between good and evil seemed clear. We were raised to respect our elders, especially parents, and taught manners and civil behavior. We were read to from Aesop’s Fables with its universal moral lessons, and we were taught accountability and personal responsibility. In school, we saluted the flag and sang the Star-Spangled Banner. We were patriots, believing in the good of America. We knew she was not perfect, for we had learned our Founders met “to form a more perfect union,” not a perfect one. Memorial Day was a big holiday for us, as was the 4th of July. We celebrated, as separate holidays, the births of George Washington and Abraham Lincoln. While we were taught humility, we were proud (and felt fortunate) to be Americans.

Yet, beneath that surface of 1950s calm lay social inequalities of which we were partially aware. Women were not treated as equals in the job market and segregation was a fact of life, and not just in the South. However, from our studies of American history we knew that progress had been made over the decades. And from our studies of world history, we learned of the uniqueness of the United States – not perfect, but better than the countries from which our ancestors had emigrated. That knowledge did not make us complacent; it made us aware of how we could effect change for the common good. In our later teens and early twenties, we witnessed historic changes in Civil and women’s rights, and we embraced those changes.

https://www.wsj.com/articles/the-attack-on-an-alzheimers-drug-11624314809?mod=opinion_lead_pos1

Public-health and media critics failed to stop federal approval of Aduhelm, Biogen’s new drug for Alzheimer’s. So now they’re mounting an assault on the drug’s cost to stop Medicare from paying for it. Their sudden and rare concern for the federal fisc is illuminating, and not in a good way.

“It’s unconscionable to ask seniors and taxpayers to pay $56,000 a year for a drug that has yet to be proven effective,” Oregon Sen. Ron Wyden tweeted after the Food and Drug Administration approved Aduhelm this month. “Medicare must be able to negotiate a fair price for prescription drugs.” He means impose price controls, while others want Medicare to restrict coverage of the drug.

The healthcare policy shop Altarum last week projected Aduhelm would increase prescription drug spending by more than 8% by mid-decade. The sages at Axios hype: “Biogen’s new Alzheimer’s treatment could be experts’ nightmare drug spending scenario: An extremely expensive product that millions of desperate patients could be eligible for—and it may not even work.” Note the bow to “experts.”

Nobody has said Aduhelm is a cure, but it is the first treatment following hundreds of failures that has shown evidence in clinical trials of removing amyloid plaque—a hallmark of the disease—and slowing cognitive decline.